Sep 8, 2026 08:00AM
Aug 13, 2026 04:05PM
Jul 27, 2026 08:04AM
Jul 27, 2026 08:00AM
May 18, 2026 08:30AM
May 14, 2026 04:10PM
May 4, 2026 08:30AM Fortress Biotech to Participate in the H.C. Wainwright 2nd Annual Royalty Company Virtual Conference
Mar 31, 2026 04:05PM
Mar 30, 2026 04:05PM
Mar 30, 2026 04:05PM
Feb 23, 2026 09:24AM
Feb 23, 2026 09:24AM
Feb 23, 2026 08:30AM
Feb 23, 2026 08:30AM Fortress Biotech’s Subsidiary Cyprium Therapeutics Enters into Agreement to Sell Rare Pediatric Disease Priority Review Voucher for $205 Million
Jan 13, 2026 07:45AM
Jan 13, 2026 07:45AM
Dec 15, 2025 08:03AM
Dec 15, 2025 08:00AM
Nov 14, 2025 08:30AM
Oct 21, 2025 08:30AM
Oct 21, 2025 08:30AM Fortress Biotech and Subsidiary Urica Therapeutics Announce First Patients Dosed in Crystalys Therapeutics’ Global Phase 3 Trials of Dotinurad for the Treatment of Gout
Oct 1, 2025 08:05AM
Oct 1, 2025 08:00AM
Sep 2, 2025 08:30AM
Aug 14, 2025 04:05PM
May 30, 2025 10:48AM
May 30, 2025 10:47AM
May 15, 2025 04:05PM Fortress Biotech Reports First Quarter 2025 Financial Results and Recent Corporate Highlights
May 13, 2025 04:15PM
May 7, 2025 08:00AM
Mar 31, 2025 04:05PM
Mar 28, 2025 08:30AM
Mar 17, 2025 08:56AM
Mar 17, 2025 08:55AM
Mar 9, 2025 10:07PM Sun Pharma to Acquire Checkpoint Therapeutics
Mar 9, 2025 10:06PM
Jan 27, 2025 08:31AM
Jan 27, 2025 08:30AM
Jan 27, 2025 08:30AM
Jan 6, 2025 08:01AM
Jan 6, 2025 08:00AM
Jan 6, 2025 08:00AM Fortress Biotech and Cyprium Therapeutics Announce U.S. FDA Acceptance and Priority Review of NDA for CUTX-101 for Treatment of Menkes Disease
Nov 14, 2024 04:10PM
Nov 14, 2024 04:10PM
Sep 26, 2024 08:30AM
Sep 20, 2024 08:31AM
Sep 20, 2024 08:30AM
Sep 4, 2024 08:30AM
Aug 13, 2024 04:05PM Fortress Biotech Reports Second Quarter 2024 Financial Results and Recent Corporate Highlights
Jul 25, 2024 08:31AM

454,623 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All